Alcon, Inc. Ownership Employees 2009 Revenues Revenues Headquarters
: Public (NYSE: ACL) : 15,700 : $6.5 billion : 6201 South Freeway Ft. Worth, TX 76134 Phone (817) 551-6878 www.alcon.com
Company introduction:
Alcon is a research r esearch and development driven, global medical specialty company focused on eye care. It is engaged in the development, manufacture and marketing of pharmaceuticals, surgical equipment and devices, and consumer eye care products for the treatment of eye disorders. The company primarily operates in the US, Japan and Switzerland. It is headquartered in Hunenberg, Switzerland and employed 15,400 people as of December December 2008. 2 008. Corporate Highlights Products: efractive: excimer lasers, wavefront wavefront aberrometer, aberrometer, microkeratome y R efractive: y
Cataract: phaco machines, custom packs, complete line of IOLs, viscoelastics, knives, sutures, cannulae, balanced salt solution, etc.
y
etinal: vitrectomy system, silicone gases, R etinal:
balanced salt solution
y
Glaucoma: glaucoma implant
y
Pharmaceutical: glaucoma, anti-infectives, anti-inflammatories, anti-inflammatories, allergy, allergy, etc.
y
OTC: contact lens care, dry eye
Strategic Market Position: Strategically
focused on important medical specialty
y
Eye care is a fast-growing health care specialty sector
y
Value
Durability
of vision in health care hierarchy of long-term growth opportunity
y
Aging global population
y
Emerging markets largely untapped for advanced eye care
y
Significant unmet clinical needs in ophthalmology ophthalmology
Alcon as unrivaled leader in eye care y
Breadth
and depth of product portfolio
y
Leading market shares across most product categories
y
Unmatched global operational infrastructure
Catalysts for Growth New Products Driving Glaucoma Growth Optonol Acquisition Further broadens Alcon¶s extensive glaucoma product offering y Sales of Ex-PR ESS® ESS® ophthalmic glaucoma device steadily building y
FINANCIAL
HIGHLIGHT S
2010
Sales by Geography
20% 46%
Emerging Markets Developed International
34%
US
The company has 3 main core businesses: Surgical, Pharmaceutical and Consumer Vision Care.
Global Sales by Product Line $900 $800 $700 $600 $500 $400 $300 $200 $100 $0
2009 2010
